Health Care & Life Sciences » Pharmaceuticals | Nippon Chemiphar Co. Ltd.

Nippon Chemiphar Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
31,893
35,119
35,602
35,688
35,331
34,182
Cost of Goods Sold (COGS) incl. D&A
15,128
18,354
18,804
19,448
19,535
19,655
Gross Income
16,765
16,765
16,798
16,240
15,796
14,527
SG&A Expense
13,438
9,921
13,653
13,403
13,947
13,063
EBIT
3,327
6,844
3,145
2,837
1,849
1,464
Unusual Expense
148
85
-
-
-
58
Non Operating Income/Expense
38
33
75
132
45
152
Interest Expense
172
158
152
136
133
129
Pretax Income
3,055
3,093
2,945
2,849
1,777
1,454
Income Tax
1,168
1,194
984
795
616
572
Consolidated Net Income
1,887
1,899
1,961
2,054
1,160
881
Net Income
1,887
1,899
1,961
2,054
1,160
881
Net Income After Extraordinaries
1,887
1,899
1,961
2,054
1,160
881
Net Income Available to Common
1,887
1,899
1,961
2,054
1,160
881
EPS (Basic)
462.00
474.35
499.01
529.92
315.15
245.04
Basic Shares Outstanding
4
4
4
4
4
4
EPS (Diluted)
461.64
474.03
498.71
529.81
315.15
245.04
Diluted Shares Outstanding
4
4
4
4
4
4
EBITDA
4,362
8,195
4,344
3,949
3,041
2,809
Non-Operating Interest Income
-
3
13
-
1
-
Equity in Affiliates (Pretax)
10
15
14
13
13
21

About Nippon Chemiphar Co.

View Profile
Address
2-2-3 Iwamoto-cho
Tokyo Tokyo 101
Japan
Employees -
Website http://www.chemiphar.co.jp
Updated 07/08/2019
Nippon Chemiphar Co., Ltd. engages in the healthcare business. It manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents. It operates through the Pharmaceuticals and Others segments.